Utreloxastat
A pharmaceutical drug used in the treatment of certain medical conditions
Utreloxastat is a pharmaceutical compound that has been investigated for its potential therapeutic effects in various medical conditions. It is primarily known for its role as an inhibitor of the enzyme semicarbazide-sensitive amine oxidase (SSAO), which is involved in the metabolism of certain biogenic amines.
Mechanism of Action[edit | edit source]
Utreloxastat functions by inhibiting the activity of SSAO, an enzyme that catalyzes the oxidative deamination of primary amines to aldehydes, ammonia, and hydrogen peroxide. This enzyme is expressed in various tissues, including the vascular endothelium, adipose tissue, and smooth muscle. By inhibiting SSAO, utreloxastat reduces the production of these reactive metabolites, which are implicated in inflammatory processes and vascular damage.
Therapeutic Applications[edit | edit source]
Utreloxastat has been explored for its potential use in treating conditions such as diabetes mellitus, where SSAO activity is often elevated. The inhibition of SSAO by utreloxastat may help in reducing vascular complications associated with diabetes by decreasing oxidative stress and inflammation.
Pharmacokinetics[edit | edit source]
The pharmacokinetic profile of utreloxastat involves its absorption, distribution, metabolism, and excretion. After administration, utreloxastat is absorbed into the bloodstream and distributed to various tissues where SSAO is active. The metabolism of utreloxastat primarily occurs in the liver, and it is excreted through the renal system.
Side Effects[edit | edit source]
As with many pharmaceutical agents, utreloxastat may have side effects. Commonly reported side effects include gastrointestinal disturbances, headache, and dizziness. It is important for patients to be monitored for any adverse reactions during treatment.
Research and Development[edit | edit source]
Research into utreloxastat is ongoing, with studies focusing on its efficacy and safety in various clinical settings. The potential for utreloxastat to be used in combination with other therapeutic agents is also being explored to enhance its clinical benefits.
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
